InvestorsHub Logo
Followers 21
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Sunday, 05/09/2021 4:17:40 PM

Sunday, May 09, 2021 4:17:40 PM

Post# of 245
Looking forward to these events:
Upcoming Events

May 11, 2021 8:00 am EDT – 10:00 am EDT
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
Abstract Title: In vitro selection and engineering of a human leukocyte antigen-independent T-cell receptor recognizing human mesothelin (Abstract # 641)
Poster Presentation: Tuesday May 11, 2021 8:00 AM - 10:00 AM EDT during the Cancer - Immunotherapy, Cancer Vaccines Session

Jun 4, 2021 1:30 pm EDT – 4:30 pm EDT
Adaptimmune Oral Presentation at ASCO 2021 Annual Meeting
Abstract Title: SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma

Session Title: Sarcoma
Teleconference dial-in information will be shared closer to the presentation date
https://www.adaptimmune.com/investors-and-media/news-events/ir-calendar
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADAP News